Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DICE Therapeutics, Inc. | Director | No securities beneficially held | 0 | Sep 14, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIGL | Vigil Neuroscience, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | Director |
DICE | DICE Therapeutics, Inc. | Sep 14, 2021 | 0 | $0 | 3 | Sep 14, 2021 | Director |
CADL | Candel Therapeutics, Inc. | Jul 26, 2021 | 0 | $0 | 3 | Jul 26, 2021 | Director |